TLC Seeks A Second Opinion On Doxolipad

 
• By David Wallace
EMA
The EMA’s CHMP Has Been Asked To Look Again At TLC’s Doxorubicin Hybrid • Source: Shutterstock

More from Regulation

More from Policy & Regulation